Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Jul;92(7):799–805. doi: 10.1111/j.1349-7006.2001.tb01164.x

Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal Truncation

Yoshihito Matsumoto 1,2,✉, Hiroshi Takano 2, Katsuzo Kunishio 1, Seigo Nagao 1, Tito Fojo 2
PMCID: PMC5926775  PMID: 11473732

Abstract

Topoisomerase Ilα is a target for many chemotherapeutic agents in clinical use. To define mechanisms of resistance and regions crucial for the function of topoisomerase IIα, drug‐resistant cell lines have been isolated following exposure to topoisomerase II poisons. Two resistant sublines, T47D‐VP and MCF‐7‐VP, were isolated from human carcinoma cell lines following exposure to 300 or 500 ng/ml etoposide (VP‐16). Cytotoxicity studies confirmed resistance to etoposide and other topoisomerase II poisons. KCl‐sodium dodecyl sulfate (K‐SDS) precipitation assays using intact cells showed reduced DNA‐topoisomerase II complex formation following VP‐16 or amsacrine (m‐AMSA). RNAse protection analysis identified a deletion of 200 base pairs in the topoisomerase Ilα cDNA of T47D‐VP and “AA insertion” in the topoisomerase Ilα cDNA of MCF‐7‐VP. Reduced topoisomerase Ila mRNA and protein levels were observed in both cell lines. It was somewhat surprising to find that nuclear extracts from T47D‐VP and MCF‐7‐VP cells had comparable topoisomerase II activity to that of parental cells. Analysis of the extent of phosphorylation demonstrated that topoisomerase Ila from the resistant cells was relatively hypophosphorylated compared to that of parental cells. In these cell lines, hypophosphorylation secondary to loss of a portion of the C‐terminal domain of topoisomerase Ilα mediated the restored activity, despite a fall in topoisomerase Ila mRNA and protein, and this resulted in cross resistance to topoisomerase II poisons.

Keywords: Topoisomerase II, Nuclear localization, Acquired drug resistance, Etoposide, Topoisomerase II poisons

Full Text

The Full Text of this article is available as a PDF (411.7 KB).

Reference

  • 1.Matsumoto , Y. , Takano , M. and Fojo , T . Cellular adaptation to drug exposure: evolution of the drug‐resistant phenotype . Cancer Res. , 57 , 5086 – 5092 ( 1997. ). [PubMed] [Google Scholar]
  • 2.Takano , H. , Kohno , K. , Ono , M. , Uchida , Y. and Kuwano , M . Increased phosphorylation of DNA topoisomerase II in etoposideresistantmutantsof humancancer KBcells . Cancer Res. , 51 , 3951 – 3957 ( 1991. ). [PubMed] [Google Scholar]
  • 3.Campain , J. A. , Gottesman , M. M. and Pastan , I . A novel mutant topoisomerase Hoc present in VP‐16‐resistant human melanoma cell lines has deletion of alanine 429 . Biochemistry , 33 , 11327 – 11332 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 4.Crenshaw , D. W. and Hsieh , T. S . Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophilamelanogaster . J. Biol. Chem. , 268 , 21335 – 21343 ( 1993. ). [PubMed] [Google Scholar]
  • 5.Wells , N. J. , Addison , C. M. , Fry , A. M. , Ganapathi , R. and Hickson , I. D . Serine 1524 is a major site of phosphorylation on human topoisomerase Hoc protein in vivo and is a substrate for casein kinase II in vitro . J. Biol. Chem. , 270 , 29746 – 29751 ( 1994. ). [PubMed] [Google Scholar]
  • 6.Wells , N. J. , Fry , A. M. , Guano , F. , Norbury , C. and Hickson , I. D . Cell cycle phase‐specific phosphorylation of human topoisomerase Hoc . J. Biol.Chem. , 269 , 28357 – 28363 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 7.Alghisi , G. C. , Roberts , E. , Cardenas , M. E. and Gasser , S. M.The regulation of DNA topoisomerase II by casein kinase II . Cell. Mol. Biol. Res. , 40 , 563 – 571 ( 1994. ). [PubMed] [Google Scholar]
  • 8.Pepperkok , R. , Lorenz , P. , Ansorge , W. and Pyerin , W . Casein kinase II is required for transition of GO/G1, early Gl, and Gl/S phase of the cell cycle . J. Biol. Chem. , 269 , 6986 – 6991 ( 1994. ). [PubMed] [Google Scholar]
  • 9.Hochhauser , D. , Stanway , C. A.Harris , A. L. and Hickson , I. D . Cloning and characterization of the 5′‐flanking region of the human topoisomerase Hoc gene . J. Biol. Chem. , 267 , 18961 – 18965 ( 1992. ). [PubMed] [Google Scholar]
  • 10.Cardenas , M. E. , Dang , Q. , Glover , C. V. C. and Gasser , S. M . Casein kinase II phosphorylates the eukaryote‐specific C‐terminal domain of topoisomerase II in vitro . EMBO J. , 11 , 1785 – 1796 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Caron , P. R. , Watt , P. and Wang , J. C . The C‐terminal domain of Saccharomyces cerevisiae DNA topoisomerase II . Mol. Cell. Biol. , 14 , 3197 – 3207 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Vassetzky , Y. S. , Dang , Q. L , Benedetiti , P. and Gasser , S. M . Topoisomerase II forms multimer in vitro: effects of metals, p‐glycerophosphate, and phosphorylation of its Cterminal domain . Mol. Cell. Biol. , 14 , 6962 – 6974 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Shiozaki , K. and Yanagida , M . Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II . J. Cell Biol. , 119 , 1023 – 1036 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Matsumoto , Y. , Sasaoka , N. , Tsuchida , T. , Fujiwara , Y. , Nagao , S. and Ohmoto , T . Fluorescent dye Rhodamine 6G as a molecular probe to study drug resistance of C6 rat glioma cells . J. Neurooncol. , 13 , 217 – 222 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 15.Melton , D. A. , Krieg , P. A. , Rebagliati , M. R. , Maniatis , T. , Zinn , K. and Green , M. R . Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter . Nucleic Acids Res. , 12 , 7035 – 7056 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mickley , L. A. , Bates , S. E. , Richert , N. D. , Currier , S. , Tanaka , S. , Foss , F. and Fojo , T . Modulation of the expression of a multidrug resistance gene (mdr‐1/P‐glycoprotein) by differentiating agents . J.Biol.Chem. , 264 , 18031 – 18040 ( 1989. ). [PubMed] [Google Scholar]
  • 17.Ishida , R. , Iwai , M. , Marsh , K. L. , Austin , C. A. , Yano , T. , Shibata , M. , Nozaki , N. and Kara , A.Threonine 1342 in human topoisomerase 11α is phosphorylated throughout the cell cycle . J. Biol. Chem. , 271 , 30077 – 30082 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 18.Wassermann , R. A. , Austin , C. A. , Fisher , L. M. and Wang , J. C.Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast . Cancer Res. , 53 , 3591 – 3596 ( 1993. ). [PubMed] [Google Scholar]
  • 19.Takano , H. , Ise , T. , Nomoto , M. , Kato , K. , Murakami , T. , Ohmori , H. , Imamura , T. , Nagatani , G. , Okamoto , T. , Ohta , R. , Furukawa , M. , Shibao , K. , Izumi , H. , Kuwano , M. and Kohno , K.Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug‐resistant cells . Anticancer Drug Des. , 14 , 87 – 92 ( 1999. ). [PubMed] [Google Scholar]
  • 20.Beck , W. T. , Kim , R. and Chen , R.Novel actions of inhibitors of DNA topoisomerase II in drug‐resistant tumor cells . CancerChemother. Pharmacol. , 34 ( Suppl. ), S14 – S18 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 21.Larsen , A.K. , Escargueil , A.E. and Skadanowski , A.Resistance mechanisms associated with altered intracellular distribution of anticancer agents . Pharmacol. Therap. , 85 , 217 – 229 ( 2000. ). [DOI] [PubMed] [Google Scholar]
  • 22.Mirski , S. E. , Gerlach , J. H. and Cole , S. P . Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II . Exp. Cell Res. , 251 , 329 – 339 ( 1999. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES